CymitQuimica logo

CAS 847862-26-4

:

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
4 produits concernés.
  • tert-Butyl(8-anti)-3-azabicyclo[3.2.1]oct-8-ylcarbamate

    CAS :
    Formule :C12H22N2O2
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :226.3153

    Ref: IN-DA00G80B

    1g
    337,00€
    5g
    À demander
    10g
    À demander
    25g
    À demander
    100mg
    115,00€
    250mg
    164,00€
    500mg
    197,00€
  • tert-Butyl (8-anti)-3-azabicyclo[3.2.1]oct-8-ylcarbamate

    CAS :
    tert-Butyl (8-anti)-3-azabicyclo[3.2.1]oct-8-ylcarbamate
    Degré de pureté :97%

    Ref: 54-OR1041732

    ne
    À demander
  • tert-butyl (8-anti)-3-azabicyclo[3.2.1]oct-8-ylcarbamate

    CAS :
    Formule :C12H22N2O2
    Degré de pureté :95.0%
    Couleur et forme :Solid
    Masse moléculaire :226.168

    Ref: 10-F385737

    1g
    453,00€
    5g
    1.410,00€
    250mg
    183,00€
  • Tert-butyl(8-anti)-3-azabicyclo[3.2.1]oct-8-ylcarbamate

    CAS :
    <p>Tert-butyl(8-anti)-3-azabicyclo[3.2.1]oct-8-ylcarbamate (tBAA) is a heterocycle that has been modified to enhance its pharmacokinetic properties. Tert-butyl(8-anti)-3-azabicyclo[3.2.1]oct-8-ylcarbamate was designed to be metabolically stable and have a high bioavailability and isosteric properties with phosphatidylinositol, which it uses as a substrate in the catalytic cycle. This modification also increased tBAA's stability in vivo, leading to an increase in efficacy. The covalent attachment of the phenyl ring on the tertiary amine nitrogen of tBAA provides additional protection against hepatic metabolism by CYP450 enzymes, making it more potent than other compounds with similar structures that are not covalently attached to the amine group.</p>
    Formule :C12H22N2O2
    Degré de pureté :Min. 95%
    Masse moléculaire :226.32 g/mol

    Ref: 3D-FT167890

    1g
    863,00€